Detection and validation of a novel major QTL for resistance to Fusarium head blight from Triticum aestivum in the terminal region of chromosome 7DL.Theor Appl Genet. 2019 Jan; 132(1):241-255.TA
Abstract
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
30327846
Citation
Ren, Junda, et al. "Detection and Validation of a Novel Major QTL for Resistance to Fusarium Head Blight From Triticum Aestivum in the Terminal Region of Chromosome 7DL." TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik, vol. 132, no. 1, 2019, pp. 241-255.
Ren J, Wang Z, Du Z, et al. Detection and validation of a novel major QTL for resistance to Fusarium head blight from Triticum aestivum in the terminal region of chromosome 7DL. Theor Appl Genet. 2019;132(1):241-255.
Ren, J., Wang, Z., Du, Z., Che, M., Zhang, Y., Quan, W., Wang, Y., Jiang, X., & Zhang, Z. (2019). Detection and validation of a novel major QTL for resistance to Fusarium head blight from Triticum aestivum in the terminal region of chromosome 7DL. TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik, 132(1), 241-255. https://doi.org/10.1007/s00122-018-3213-4
Ren J, et al. Detection and Validation of a Novel Major QTL for Resistance to Fusarium Head Blight From Triticum Aestivum in the Terminal Region of Chromosome 7DL. Theor Appl Genet. 2019;132(1):241-255. PubMed PMID: 30327846.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Detection and validation of a novel major QTL for resistance to Fusarium head blight from Triticum aestivum in the terminal region of chromosome 7DL.
AU - Ren,Junda,
AU - Wang,Zhen,
AU - Du,Ziyi,
AU - Che,Mingzhe,
AU - Zhang,Yibin,
AU - Quan,Wei,
AU - Wang,Yongji,
AU - Jiang,Xu,
AU - Zhang,Zhongjun,
Y1 - 2018/10/16/
PY - 2018/01/15/received
PY - 2018/10/12/accepted
PY - 2018/10/18/pubmed
PY - 2019/4/19/medline
PY - 2018/10/18/entrez
SP - 241
EP - 255
JF - TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik
JO - Theor Appl Genet
VL - 132
IS - 1
N2 - KEY MESSAGE: A novel QTL for FHB resistance was mapped on wheat 7DL, being effective in multiple genetic backgrounds and environments, and comparable to Fhb1 in effect magnitude. Fusarium head blight (FHB) is one of the major fungal diseases affecting wheat production in many countries. The wheat line AQ24788-83 (AQ) possesses FHB resistance. The American wheat cultivar Luke is FHB susceptible. A Luke × AQ population consisting of 1652 advanced recombinant inbred lines (RILs) was developed, from which 272 RILs were randomly sampled and used to construct a linkage map. Another 154 RILs were selected for homogeneity in plant height (PH) and flowering date (FD). This selection strategy was adopted to reduce possible confounding effects on FHB assessment due to variation in PH and FD. The 272 and 154 RILs were genotyped applying simple sequence repeat (SSR), diversity arrays technology (DArT) and single-nucleotide polymorphism (SNP) markers. The two sets of RILs were evaluated for FHB resistance applying point inoculation in greenhouses; the 154 RILs were also evaluated applying spray inoculation in multiple field environments. The linkage map consisted of 2088 SSR, DArT, and SNP markers. A FHB resistance quantitative trait locus (QTL), designated as QFhb.cau-7DL, was detected on chromosome arm 7DL; this QTL was closely linked to the SSR marker gwm428 (http://www.wheat.pw.usda.gov/ggpages/SSR/). QFhb.cau-7DL was significantly effective (α = 0.01) in every test trial, and its effectiveness was validated using three additional wheat crosses. Sumai 3 (donor wheat of the FHB resistance gene Fhb1) was used in one of these crosses. QFhb.cau-7DL was comparable to Fhb1 in effect magnitude, providing a great potential for improving FHB resistance.
SN - 1432-2242
UR - https://www.unboundmedicine.com/medline/citation/30327846/Detection_and_validation_of_a_novel_major_QTL_for_resistance_to_Fusarium_head_blight_from_Triticum_aestivum_in_the_terminal_region_of_chromosome_7DL_
L2 - https://dx.doi.org/10.1007/s00122-018-3213-4
DB - PRIME
DP - Unbound Medicine
ER -